The Global Endocrine Pharmaceutical Market 2005

Questions: Discounts, Updates etc.

Pages: 194

Price (Single): £1,499

Price (Departmental): £2,999

Price (Company): £4,499

Publication Date: 2005-03-18

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Today, the global endocrine pharmaceutical market is a highly lucrative multi-billion dollar business, but, can you confidently answer the following?

  • What endocrine diseases will be successful?
  • What endocrine diseases will lose out?
  • What area of endocrine do you need to invest in?
  • Which areas of endocrine do you need to avoid?
  • Who are the key players in the endocrine market?
  • How much is the total global endocrine market worth today and in the future?
  • What are the major changes to the endocrine market?
  • Are there any newcomer's of importance?
  • What is in the endocrine pipeline?


Know the answer to all these questions and much more in visiongains latest global endocrine pharmaceutical market report.

Visiongain values the total global endocrine market at $43.2bn in 2005, a growth of 13.5% from 2004. The endocrine diseases market is expected to grow over 100% over the forecast period, to produce revenues in 2010 of just under $70bn. Major changes of the market are expected over the forecast period, such as the arrival of insulin delivery technologies and massive losses of the hypothyroidism market due to increasing generic competition.

For in-depth analysis of these changes it is vital that you purchase Endocrine 2005. Designed as an essential business aid, Endocrine 2005 provides a thorough evaluation of the market for you to keep ahead of your competitors.

Learn about the four therapeutic area major earners of the industry:

  1. Hypertension
  2. Diabetes
  3. Osteoporosis
  4. Infertility

In addition, Endocrine 2005 also features market analysis of the following:

  • Growth Hormone Replacement
  • Acromegaly
  • Hypothyrodism and Hyperthyrodism

Why You Must Buy This Report

This 170+ paged report features 50+ tables, 20+ graphs and 20+ charts, news, insights, the very latest developments and an in-depth review of the endocrine market with up to date analysis. This report is a vital addition to gaining an understanding of this lucrative area of the pharmaceutical market, and will give your company 'the edge' of your competitors. You can not afford to be without this latest report from visiongain.

Table of Contents

  • Chapter 1: Executive Summary

  • Chapter 2: The Global Endocrine Disease Market

  • Chapter 3 The Global Pituitary Disease Market

  • Chapter 4: The Global Hypertensive Market

  • Chapter 5: The Global Diabetes Market

  • Chapter 6: The Global Infertility Market

  • Tables
  • Table 1.1: The Global Endocrine Diseases Market, 2003-2010
  • Table 1.2: The Endocrine System
  • Table 1.3: Endocrine Diseases
  • Table 2.1: Global Forecast Revenues ($m) for the Endocrine Disease Market, 2003-2010
  • Table 2.2: Changes in Market Share (%) Between 2003 and 2010 of the Major Endocrine Disease Markets
  • Table 2.3: Global Revenues ($m) 2003 and 2010 for all Endocrine Diseases
  • Table 2.4: Global Revenues ($m) and Growth Rates (%) for the Pharmaceutical Treatment of Endocrine Disease, 2004
  • Table 2.5: Global Revenues, 2003 and 2010, for the Main Pharmaceutical Treatment Areas of Endocrine Disease
  • Table 2.6: Global Revenue ($m) by Country Region, 2004
  • Table 3.1: The Hormones Secreted by the Anterior Pituitary
  • Table 3.2: Global Revenues ($m) for Sandostatin, 2002 and 2003
  • Table 3.3: The 2003 Global Acromegaly Market: Revenues and Market Share by Drug
  • Table 3.4: The 2010 Global Acromegaly Market: Revenues and Market Share by Drug
  • Table 3.5: World Acromegaly Market Revenue Forecast by Drug, 2003-2010
  • Table 3.6: Acromegaly Pipeline Portfolio, 2005
  • Table 3.7: Global Market Revenues ($m) for GH Replacement Drugs, 2002 & 2003
  • Table 3.8: Global GH Replacement Drugs Market Share, 2002 & 2003
  • Table 3.9: Global Forecast Revenues ($m) and Growth Rates (%) for GH Replacement Drugs, 2003-2010
  • Table 3.10: Growth Hormone Replacement Drug Pipeline Portfolio, 2005
  • Table 4.1: The Global Market for Hypertension Drugs, 2003
  • Table 4.2, The Global Market for Hypertensive Drugs by Company, 2003
  • Table 4.3, Global Market Share for Hypertensive Drugs, 2003
  • Table 4.4: Endocrine Controlled Hypertensives Market, 2003
  • Table 4.5: Total Endocrine Hypertensive Drug Market Forecast ($m) by Class, 2003-2010
  • Table 4.6: Hypertensive Pipeline Products in Late Developmental Stages, 2005
  • Table 5.1: Global Market ($m) and Growth Rates for Diabetes Drugs, 2003
  • Table 5.2: The Global Market ($m) for Diabetic Drugs by Class, 2002 & 2003
  • Table 5.3: The Global Market ($m) for Diabetic Drugs by Company, 2002 & 2003
  • Table 5.4: Oral and Human Insulin Diabetes Drugs Market Share (%), 2002 & 2003
  • Table 5.5: 2005-2007 Pipeline Diabetes Drugs with Blockbuster Potential
  • Table 5.6: Total Global Diabetes Market Revenue (Sm) Forecast for Insulins & Oral AntiDiabetic Drugs, 2003-2010
  • Table 5.7: Late-Stage Development Diabetes Pipeline Product Portfoilo, 2005
  • Table 6.1: Global Infertility Drug Market ($m) and Growth Rate (%), 2002 & 2003
  • Table 6.2: Serono's Infertility Drug Portfolio Performance, 2003 and 2004
  • Table 6.3: Total Global Infertility Drug Market Revenue ($m), 2002 & 2003
  • Table 6.4: Global Market Share (%) by Fertility Drug Class, 2002 & 2003
  • Table 6.5: Global Market Share (%) by Company, 2003
  • Table 6.6: Total Global Infertility Drug Market Revenue Forecast ($m), 2003-2010
  • Table 6.7: Global Infertility Drug Market Revenue Forecast ($m), 2003-2010 by Class
  • Table 6.8: Infertility Pharmaceutical Pipeline Portfolio, 2005
  • Table 7.1: Global Market ($m) and Growth Rates for Osteoporoitic Drugs, 2003
  • Table 7.2: The Global Market ($m) for Osteoporosis Drugs by Drug Type, 2002 & 2003
  • Table 7.3: Osteoporosis Company Market Share by Revenue ($m), 2002 & 2003
  • Table 7.4: Total Global Osteoporosis Drug Market Revenue Forecast ($m), 2003-2010
  • Table 7.5: Total Global Osteoporosis Market Revenue ($m) By Drug Class, 2003-2010
  • Table 7.6: Osteoporosis Pipeline Product Portfolio, 2005
  • Table 8.1: Hypothyrodism Drug Products Available, 2005
  • Table 8.2: Hypothyrodism Market Revenues ($m), 2002 & 2003 by Drug
  • Table 8.3: Hypothyrodism Market Share (%) 2002 & 2003 by Drug
  • Table 8.4: Global Forecast for Revenue ($m) Growth of the Hypothyroid Market, 2003-2010
  • Table 8.5: Global Revenues (£$m) for the Hyperhyroid Market, 2004
  • Table 9.1 Indications of Medrol, 2005
  • Table 9.2: Adrenocortical Pharmaceuticals, 2005

  • Graphs
  • Graph 1.1: Total Global Endocrine Market Revenues ($bn), 2003-2010
  • Graph 1.2: Total Global Endocrine Market Growth (%), 2004-2010
  • Graph 2.1: Total Endocrine Pharmaceutical Market Revenue ($m) Forecast by Diease, 2003-2010
  • Graph 2.2 Endocrine Therapeutic Area Revenues ($m), 2003 & 2010
  • Graph 3.1: Total Acromegaly Market Revenue ($m) Forecast 2003-2010 by Drug
  • Graph 3.2: Total Acromegaly Market Revenue ($m) Forecast 2003-2010
  • Graph 3.3: Total Acromegaly Market Revenue Change (%) Forecast 2003- 2010
  • Graph 3.4: Total World GH Replacement Drug Market Revenue Forecast ($m), 2003-2010
  • Graph 3.5: Total World GH Replacement Drug Market Revenue Change Forecast (%), 2003-2010
  • Graph 4.1: World Endocrine Hypertensive Drug Market Revenue ($m) by Class, 2003-2010
  • Graph 4.2: Total World Endocrine Hypertensive Drug Market Revenue ($m), 2003-2010
  • Graph 4.3: Total World Endocrine Hypertensive Drug Market Revenue Growth (%), 2004-2010
  • Graph 5.1: Total Global Diabetes Market Revenue (Sbn) Forecast, 2003- 2010
  • Graph 5.2: Total Global Diabetes Market Growth (%) Forecast, 2003-2010
  • Graph 5.3: Total Global Diabetes Market Revenue Forecast ($m), for Insulins and Oral Anti-Diabetes Drugs, 2003-2010
  • Graph 6.1: Total Global Infertility Drug Market Revenue Forecast ($m), 2003-2010
  • Graph 6.2: Total Global Infertility Drug Market Growth Forecast (%), 2003-2010
  • Graph 6.3: Global Infertility Drug Market Revenue Forecast ($m), 2003-2010 by Class
  • Graph 7.1: Total Global Osteoporosis Market Revenue ($m), 2003-2010
  • Graph 7.2: Total Global Osteoporosis Market Revenue Growth (%), 2003-2010
  • Graph 7.3: Total Global Osteoporosis Market Revenue ($m) By Drug Class, 2003-2010
  • Graph 8.1: Total Global Hypotension Market Revenue ($m), 2003-2010
  • Graph 8.2: Total Global Hypotension Market Revenue Loss (%), 2003-2010

  • Charts
  • Chart 2.1: Total Global Endocrine Market Share (%) by Disease, 2003
  • Chart 2.2: Total Global Endocrine Market Share (%) by Disease, 2010
  • Chart 2.3: Global Endocrine Market Share (%) by Country Region, 2004
  • Chart 3.1: Acromegaly Market Share %, 2003
  • Chart 3.2: Acromegaly Market Share %, 2010
  • Chart 3.3: GH Replacement Drugs Market Share (%), 2002
  • Chart 3.4: GH Replacement Drugs Market Share (%), 2003
  • Chart 4.1: Hypertensive Market Share by Company, 2003
  • Chart 4.2: Hypertensive Market Share by Drug Class, 2003
  • Chart 5.1: Diabetes Market Share by Drug Class, 2002
  • Chart 5.2: Diabetes Market Share by Drug Class, 2003
  • Chart 5.3: Diabetes Market Share by Company, 2002
  • Chart 6.1: Global Fertility Drug Market Share (%) by Drug Class, 2002
  • Chart 6.2: Global Fertility Drug Market Share (%) by Drug Class, 2003
  • Chart 6.3: Global Fertility Drug Market Share (%) by Company,
  • Chart 6.4: Global Infertility Drug Market Share (%) by Class, 2010
  • Chart 7.1: Total Osteoporotic Market Share (%) by Drug Class, 2002
  • Chart 7.2: Total Osteoporotic Market Share (%) by Drug Class, 2003
  • Chart 7.3: Total Osteoporotic Company Market Share (%), 2002
  • Chart 7.4: Total Osteoporotic Company Market Share (%), 2003
  • Chart 8.1: Hypothyrodism Market Share %, 2002
  • Chart 8.2: Hypothyrodism Market Share %, 2003

    • Other users found this report page using the following search terms: diabetes osteoporosis infertility growth hormone replacement acromegaly hypothyrodism hyperthyrodism market endocrine graphs pharmaceutical diabetes global share graph osteoporosis acromegaly

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.